Here is what the news looks like in a 10pt Verdana, White Background, Bold Bullet Statements

Please Note:  Some of the links below might not be active  - this page is here just so that you can get an idea of what the Pharmaceutical News Harvest(R) might look like on your site.

9/7 90-Day Pain Narcotic Prescriptions Under Consideration; 30-day limit up till now could go bye-bye:
Feds May Ease Limit on Painkillers … People taking Oxycontin, codeine and other powerful painkillers for chronic pain could get a 90-day supply, under a proposal Wednesday that would let patients avoid repeated doctor visits to get more than 30-day prescriptions…[ AP/Newsday; Hope Yen]

9/7 Feds Say No Flu Shot Shortage This Year
No wait expected for flu shots this year … more than 100 million doses are expected over the next several months… In 2004, production problems at one manufacturer caused severe shortages and hours-long lines for shots. Last September, tight supplies caused doctors to limit shots at first …[ AP/Yahoo; MIKE STOBBE]

9/7 GSK Wins EU Reimportation Decision
GSK gets positive decision in parallel trade case … favourable decision in a long-running dispute over its decision to limit supplies of three drugs to Greece to prevent them being sold cheaply elsewhere in Europe…. [ Reuters ]

9/7 Fragmin Wider Use Gets Green-lighted
US panel backs Pfizer drug for cancer patients …  Japan's Eisai Co Ltd. owns the rights to promote Fragmin in the United States … Fragmin effectively prevents blood clots in cancer patients and warrants wider approval… [ Reuters; Susan Heavey]

9/7 FDA Panel Torpedoes Leukemia Drug Genasense
FDA Panel Votes Against Leukemia Drug …  reviewers said that more leukemia patients responded to chemotherapy when the Genasense is added to their treatment mix, but cautioned that the overall difference is of "questionable clinical significance…[ AP/Newsday ]
US experts reject Genta drug for blood cancer … chronic lymphocytic leukemia (CLL) responded to chemotherapy when Genasense was added, it did not extend survival or the time it took for the leukemia to advance… [ Reuters; Susan Heavey]

9/7 Vioxx Plaintiff Lawyer Excoriates Merck's
internal Vioxx investigation:
Merck Handled Vioxx `With Integrity,' Study Concludes …  findings are bogus,'' said plaintiff's attorney Mark Lanier, who won a $253 million verdict against Merck in a Vioxx case last year. ``This was clearly orchestrated for the stock analysts. It's bought and paid for. The firm that did it, which is a notorious anti-plaintiffs' firm, claims to be independent…[ Bloomberg;  David Voreacos and Angela Zimm]
Merck board-requested probe backs it on Vioxx … 20-month review of the drug company's conduct concluded Merck management "acted with integrity" in the development and marketing of Vioxx … report found no member of Merck management tried to mislead scientists or consumers… [ Reuters; Lewis Krauskopf]
See Also> MULTIMEDIA [Video presentation via Wall Street Journal]
See Also> Click Here for actual report [from Wall Street Journal]

9/7 Mylan Wins Ditropan XL Patent Battle
US court backs Mylan on generic incontinence drug … upheld the decision by the U.S. District Court for the Northern District of West Virginia that Mylan's unique delivery system for the generic version of Ditropan XL did not infringe Alza's patent and declared the patent invalid…. [ Reuters ]

9/7 Glaxo's DPT Vaccine Factory Comes Online This Week
Glaxo to open 100 mln euro Hungary vaccine unit ...will be one of Europe's most advanced biotechnology plants and it will manufacture two types of vaccines … plans to manufacture DPT … [ Reuters ]


**************************************************************

Here is what the news looks like in a 9pt Verdana format :

[Please Note:  Some of the links below might not be active  - this page is here just so that you can get an idea of what the Pharmaceutical News Harvest(R) might look like on your site]

9/7 90-Day Pain Narcotic Prescriptions Under Consideration; 30-day limit up till now could go bye-bye:
Feds May Ease Limit on Painkillers … People taking Oxycontin, codeine and other powerful painkillers for chronic pain could get a 90-day supply, under a proposal Wednesday that would let patients avoid repeated doctor visits to get more than 30-day prescriptions…[ AP/Newsday; Hope Yen]

9/7 Feds Say No Flu Shot Shortage This Year
No wait expected for flu shots this year … more than 100 million doses are expected over the next several months… In 2004, production problems at one manufacturer caused severe shortages and hours-long lines for shots. Last September, tight supplies caused doctors to limit shots at first …[ AP/Yahoo; MIKE STOBBE]

9/7 GSK Wins EU Reimportation Decision
GSK gets positive decision in parallel trade case … favourable decision in a long-running dispute over its decision to limit supplies of three drugs to Greece to prevent them being sold cheaply elsewhere in Europe…. [ Reuters ]

9/7 Fragmin Wider Use Gets Green-lighted
US panel backs Pfizer drug for cancer patients …  Japan's Eisai Co Ltd. owns the rights to promote Fragmin in the United States … Fragmin effectively prevents blood clots in cancer patients and warrants wider approval… [ Reuters; Susan Heavey]

9/7 FDA Panel Torpedoes Leukemia Drug Genasense
FDA Panel Votes Against Leukemia Drug …  reviewers said that more leukemia patients responded to chemotherapy when the Genasense is added to their treatment mix, but cautioned that the overall difference is of "questionable clinical significance…[ AP/Newsday ]
US experts reject Genta drug for blood cancer … chronic lymphocytic leukemia (CLL) responded to chemotherapy when Genasense was added, it did not extend survival or the time it took for the leukemia to advance… [ Reuters; Susan Heavey]

9/7 Vioxx Plaintiff Lawyer Excoriates Merck's
internal Vioxx investigation:
Merck Handled Vioxx `With Integrity,' Study Concludes …  findings are bogus,'' said plaintiff's attorney Mark Lanier, who won a $253 million verdict against Merck in a Vioxx case last year. ``This was clearly orchestrated for the stock analysts. It's bought and paid for. The firm that did it, which is a notorious anti-plaintiffs' firm, claims to be independent…[ Bloomberg;  David Voreacos and Angela Zimm]
Merck board-requested probe backs it on Vioxx … 20-month review of the drug company's conduct concluded Merck management "acted with integrity" in the development and marketing of Vioxx … report found no member of Merck management tried to mislead scientists or consumers… [ Reuters; Lewis Krauskopf]
See Also> MULTIMEDIA [Video presentation via Wall Street Journal]
See Also> Click Here for actual report [from Wall Street Journal]

9/7 Mylan Wins Ditropan XL Patent Battle
US court backs Mylan on generic incontinence drug … upheld the decision by the U.S. District Court for the Northern District of West Virginia that Mylan's unique delivery system for the generic version of Ditropan XL did not infringe Alza's patent and declared the patent invalid…. [ Reuters ]

9/7 Glaxo's DPT Vaccine Factory Comes Online This Week
Glaxo to open 100 mln euro Hungary vaccine unit ...will be one of Europe's most advanced biotechnology plants and it will manufacture two types of vaccines … plans to manufacture DPT… [ Reuters ]


Click Here for more information regarding licensing our unbranded content.
Click Here to return to Home Page 
Click Here to read our Mission Statement